Ian Ingram is the Deputy Managing Editor for MedPage Today, a leading source of medical news and information for healthcare professionals. With a focus on medical research and advancements, Ian covers a wide range of topics including oncology, hematology, and drug approvals.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Ian Ingram's coverage is primarily focused on healthcare and pharmaceuticals, with a particular emphasis on clinical trial results, FDA approvals, and drug treatments for cancer and leukemia. He frequently cites data in his articles, indicating an interest in evidence-based reporting.
Pitching to Ian should involve providing access to newly released or exclusive clinical trial data, insights from key opinion leaders in the field of oncology or pharmaceuticals regarding recent developments in cancer treatment or FDA approval processes.
It's important to note that Ian does not have a specific geographic focus but covers international healthcare and pharmaceutical topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery
— An immediate appointment to a smoking cessation clinic shows benefit versus usual care
— Investigational depemokimab succeeds in patients with high blood eosinophil count
By: Ian Ingram
— They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
— "We should be cautious about using drugs off-label," investigator says
— In trials, guselkumab more than doubled remission rates versus placebo
By: Ian Ingram
— One negative trial in the phase III PROMIS program blamed squarely on the COVID-19 pandemic
— Other studies looked at steroids for kids with pneumonia and a link between asthma and fertility
— 38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks
— Benralizumab wins approval for eosinophilic granulomatosis with polyangiitis
(833) 317-6278 
